
|Videos|July 14, 2023
Treatment Options for PEComas After Progression on Nab-Sirolimus
A review of the available treatment options for a patient with PEComa who have disease progression after nab-sirolimus.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
2026 ASCO Plenary Delivers Practice-Changing Progress
2
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
3
FDA Grants ODD to LRRC15-Targeting ADC SOT106 for Osteosarcoma
4
FDA Clears US Enrollment for Ateganosine Phase 2 NSCLC Trial Expansion
5






































